Published in Am J Gastroenterol on February 01, 2005
Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests | NCT00258869
A biomarker panel for acute graft-versus-host disease. Blood (2008) 3.83
Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat Rev Drug Discov (2006) 3.83
Human body fluid proteome analysis. Proteomics (2006) 2.39
Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol (2008) 2.20
Cytokine expression patterns associated with systemic adverse events following smallpox immunization. J Infect Dis (2006) 1.29
Development and standardization of multiplexed antibody microarrays for use in quantitative proteomics. Proteome Sci (2004) 1.26
Cytokines as biomarkers in rheumatoid arthritis. Mediators Inflamm (2014) 1.16
Cytokine-producing dendritic cells in the pathogenesis of inflammatory skin diseases. J Clin Immunol (2009) 1.08
Integrated analysis of genetic and proteomic data identifies biomarkers associated with adverse events following smallpox vaccination. Genes Immun (2008) 1.08
New serological biomarkers of inflammatory bowel disease. World J Gastroenterol (2008) 1.06
Proteomic profiling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the inflammatory colitides. Inflamm Bowel Dis (2010) 1.06
Applications of proteomics in the study of inflammatory bowel diseases: Current status and future directions with available technologies. Inflamm Bowel Dis (2009) 1.05
Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. Antioxid Redox Signal (2013) 0.99
Gastrointestinal lymphatics in health and disease. Pathophysiology (2010) 0.98
The use of variations in proteomes to predict, prevent, and personalize treatment for clinically nonfunctional pituitary adenomas. EPMA J (2010) 0.96
Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease. PLoS One (2011) 0.94
Smad3 knockout mice exhibit impaired intestinal mucosal healing. Lab Invest (2008) 0.93
Proteomic patterns of colonic mucosal tissues delineate Crohn's colitis and ulcerative colitis. Proteomics Clin Appl (2013) 0.92
Interleukin-7 receptor blockade suppresses adaptive and innate inflammatory responses in experimental colitis. J Inflamm (Lond) (2012) 0.82
Current advantages in the application of proteomics in inflammatory bowel disease. Dig Dis Sci (2012) 0.82
Markers of Inflammation and Lineage on Exfoliated Colonic Cells In Pediatric Inflammatory Bowel Disease. J Gastrointest Dig Syst (2011) 0.82
Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides. Clin Med Insights Gastroenterol (2015) 0.81
Perspectives of the relationship between IL-7 and autoimmune diseases. Clin Rheumatol (2013) 0.80
TGFbeta1 expression in colonic mucosa: modulation by dietary lipids. Genes Nutr (2007) 0.77
Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics. World J Gastrointest Surg (2014) 0.76
Microbial Disruption of Autophagy Alters Expression of the RISC Component AGO2, a Critical Regulator of the miRNA Silencing Pathway. Inflamm Bowel Dis (2015) 0.76
The mRNA level of the transforming growth factor β1 gene, but not the amount of the gene product, can be considered as a potential prognostic parameter in inflammatory bowel diseases in children. Int J Colorectal Dis (2012) 0.76
Cerebral magnetic resonance imaging in quiescent Crohn's disease patients with fatigue. World J Gastroenterol (2017) 0.75
Elevated systemic interleukin-7 in patients with colorectal cancer and individuals at high risk of cancer: association with lymph node involvement and tumor location in the right colon. Cancer Immunol Immunother (2016) 0.75
Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation. Mucosal Immunol (2017) 0.75
Oral Administration of Lactobacillus rhamnosus GG Ameliorates Salmonella Infantis-Induced Inflammation in a Pig Model via Activation of the IL-22BP/IL-22/STAT3 Pathway. Front Cell Infect Microbiol (2017) 0.75
Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J (1955) 19.22
Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol (2003) 15.65
CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol (2002) 12.73
Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med (2002) 7.11
Transforming growth factor-beta in T-cell biology. Nat Rev Immunol (2002) 4.50
Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol Rev (2001) 3.70
Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology (1994) 3.60
The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem (1996) 3.53
Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev (2001) 3.31
Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology (1993) 3.20
Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology (1992) 3.04
Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol (1995) 2.90
Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat Biotechnol (2002) 2.86
Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med (1996) 2.68
Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol (2001) 2.65
Proinflammatory and immunoregulatory functions of interleukin-12. Int Rev Immunol (1998) 2.32
IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood (2002) 2.31
An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol (1992) 1.99
Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology (1992) 1.98
Evaluation of disease activity in patients with moderately active ulcerative colitis: comparisons between a new activity index and Truelove and Witts' classification. Am J Gastroenterol (1995) 1.85
A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease. Eur J Gastroenterol Hepatol (1997) 1.85
Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology (1997) 1.69
Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. Blood (2000) 1.60
Cytokines, chemokine receptors, and homing molecule distribution in the rectum and stomach of pediatric patients with ulcerative colitis. J Pediatr Gastroenterol Nutr (2003) 1.55
Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes. J Immunol (2003) 1.54
CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease. Gastroenterology (2001) 1.48
Immunobiology of interleukin-12. Immunol Res (1998) 1.48
Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene (1995) 1.44
Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease. Gastroenterology (1993) 1.35
Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin Exp Immunol (1995) 1.30
Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis. Ann Rheum Dis (2003) 1.28
Differential regulation of interleukin-12 p40 and p35 induction via Erk mitogen-activated protein kinase-dependent and -independent mechanisms and the implications for bioactive IL-12 and IL-23 responses. Immunology (2003) 1.23
Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collagen deposition in IBD intestine. Inflamm Bowel Dis (2001) 1.22
IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-gamma. J Immunol (1995) 1.19
Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity. Gut (1990) 1.14
Interleukin-12, a key cytokine in Th1-mediated autoimmune diseases. Cell Mol Life Sci (1999) 1.13
The role of suppressor T cells in regulation of immune responses. J Allergy Clin Immunol (2002) 1.12
Cell-fate decisions in early T cell development: regulation by cytokine receptors and the pre-TCR. Semin Immunol (1999) 1.10
Synergistic effects of IL-7 and IL-12 on human T cell activation. J Immunol (1995) 1.08
Biological and clinical implications of interleukin-7 and lymphopoiesis. Cytokines Cell Mol Ther (1999) 1.07
Inflammatory bowel disease mucosal biopsies have specialized lymphokine mRNA profiles. Inflamm Bowel Dis (1996) 1.02
Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease. Dig Dis Sci (1999) 1.01
Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. J Allergy Clin Immunol (1996) 0.99
Salicylates used in inflammatory bowel disease and colchicine impair interferon-gamma induced HLA-DR expression. Gut (1992) 0.99
Cytokines and inflammatory bowel disease. Baillieres Clin Gastroenterol (1996) 0.97
Anti-inflammatory cytokines: expression and action in the brain. Neuroimmunomodulation (2001) 0.97
Transforming growth factor-beta as a regulator of site-specific T-cell inflammatory response. Scand J Immunol (2003) 0.96
Diverse immunological and hematological effects of interleukin 7: implications for clinical application. J Leukoc Biol (1995) 0.94
Cytokines in inflammatory bowel disease. Scand J Gastroenterol (1992) 0.91
Interleukin 7 can enhance antigen-specific cytotoxic-T-lymphocyte and/or Th2-type immune responses in vivo. Clin Diagn Lab Immunol (2000) 0.90
Rapid up-regulation of alpha4 integrin-mediated leukocyte adhesion by transforming growth factor-beta1. Mol Biol Cell (2003) 0.89
Site-specific changes in transforming growth factor-alpha and -beta1 expression in colonic mucosa of adolescents with inflammatory bowel disease. Scand J Gastroenterol (1999) 0.87
Rheumatoid arthritis exacerbation caused by exogenous interleukin-12. Arthritis Rheum (2000) 0.84
Pitfalls in cytokine analysis in inflammatory bowel disease. Aliment Pharmacol Ther (1996) 0.83
Downregulation of interleukin-12 (IL-12) responsiveness in human T cells by transforming growth factor-beta: relationship with IL-12 signaling. Blood (1999) 0.81
Regulation of interleukin 12 p40 and p70 production by blood and alveolar phagocytes during severe sepsis. Lab Invest (2003) 0.80
Interleukin-7 treatment promotes the differentiation pathway of T-cell-receptor-alpha beta cells selectively to the CD8+ cell lineage. Immunology (1997) 0.80
Mucosal T cells as a target for treatment of IBD. J Gastroenterol (2003) 0.78
Alternative isoform regulation in human tissue transcriptomes. Nature (2008) 52.76
Comprehensive human genome amplification using multiple displacement amplification. Proc Natl Acad Sci U S A (2002) 13.58
Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med (2011) 8.20
A highly annotated whole-genome sequence of a Korean individual. Nature (2009) 6.91
Unbiased whole-genome amplification directly from clinical samples. Genome Res (2003) 6.29
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med (2010) 4.95
Transcriptome sequencing of malignant pleural mesothelioma tumors. Proc Natl Acad Sci U S A (2008) 4.75
A single IGF1 allele is a major determinant of small size in dogs. Science (2007) 4.68
Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature (2010) 3.90
Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol (2006) 3.86
Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat Biotechnol (2002) 2.86
Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat Genet (2003) 2.78
Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med (2006) 2.53
Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest (2003) 2.27
Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc Natl Acad Sci U S A (2002) 2.26
An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med (2013) 2.23
Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum. PLoS One (2008) 2.22
Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood (2002) 2.11
Management of High-Throughput DNA Sequencing Projects: Alpheus. J Comput Sci Syst Biol (2008) 1.85
Beta-arrestin-2 regulates the development of allergic asthma. J Clin Invest (2003) 1.85
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling. Blood (2006) 1.83
Cerebral palsy is characterized by protein mediators in cord serum. Ann Neurol (2004) 1.73
Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control. J Infect Dis (2003) 1.71
Multiplex PCR to diagnose bloodstream infections in patients admitted from the emergency department with sepsis. J Clin Microbiol (2009) 1.63
Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum (2006) 1.62
Genome sequencing and mapping reveal loss of heterozygosity as a mechanism for rapid adaptation in the vegetable pathogen Phytophthora capsici. Mol Plant Microbe Interact (2012) 1.59
CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. Arterioscler Thromb Vasc Biol (2007) 1.59
Genomic-based therapy: targeting interleukin-1 for autoinflammatory diseases. Arthritis Rheum (2004) 1.58
Risk factors for mortality in lower intestinal bleeding. Clin Gastroenterol Hepatol (2008) 1.55
Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis. Acad Emerg Med (2010) 1.54
The aging feline kidney: a model mortality antagonist? J Feline Med Surg (2006) 1.50
Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes. J Exp Med (2004) 1.48
A host-based RT-PCR gene expression signature to identify acute respiratory viral infection. Sci Transl Med (2013) 1.46
T cell repertoire development in humans with SCID after nonablative allogeneic marrow transplantation. J Immunol (2003) 1.39
A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2. PLoS One (2013) 1.37
Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis. Mol Pharmacol (2005) 1.33
Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation. J Immunol (2004) 1.33
CX3CR1 tyrosine sulfation enhances fractalkine-induced cell adhesion. J Biol Chem (2002) 1.30
Cytokine expression patterns associated with systemic adverse events following smallpox immunization. J Infect Dis (2006) 1.29
Acute LPS inhalation in healthy volunteers induces dendritic cell maturation in vivo. J Allergy Clin Immunol (2005) 1.27
Discriminative value of inflammatory biomarkers for suspected sepsis. J Emerg Med (2011) 1.26
Toll-like receptor 4 (TLR4)-deficient murine macrophage cell line as an in vitro assay system to show TLR4-independent signaling of Bacteroides fragilis lipopolysaccharide. Infect Immun (2002) 1.21
Measuring proteins on microarrays. Curr Opin Biotechnol (2002) 1.18
Identification of diagnostic biomarkers for infection in premature neonates. Mol Cell Proteomics (2008) 1.18
The Chediak-Higashi protein interacts with SNARE complex and signal transduction proteins. Mol Med (2002) 1.18
Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humans. J Immunol (2011) 1.14
Multiplexed protein profiling on antibody-based microarrays by rolling circle amplification. Curr Opin Biotechnol (2003) 1.14
Increased acute inflammation, leukotriene B4-induced chemotaxis, and signaling in mice deficient for G protein-coupled receptor kinase 6. J Immunol (2003) 1.10
Chemokines and leukocyte trafficking in rheumatoid arthritis. Pathophysiology (2005) 1.04
CX3CR1 deficiency confers protection from intimal hyperplasia after arterial injury. Arterioscler Thromb Vasc Biol (2006) 1.04
Diagnosis of mitochondrial disorders by concomitant next-generation sequencing of the exome and mitochondrial genome. Genomics (2013) 1.04
The gene for the muted (mu) mouse, a model for Hermansky-Pudlak syndrome, defines a novel protein which regulates vesicle trafficking. Hum Mol Genet (2002) 1.02
Ozone enhancement of lower airway allergic inflammation is prevented by gamma-tocopherol. Free Radic Biol Med (2007) 1.00
Gene expression-based classifiers identify Staphylococcus aureus infection in mice and humans. PLoS One (2013) 0.99
De novo frameshift mutation in ASXL3 in a patient with global developmental delay, microcephaly, and craniofacial anomalies. BMC Med Genomics (2013) 0.98
The immune system in aging: roles of cytokines, T cells and NK cells. Front Biosci (2005) 0.98
Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak-like primary immunodeficiency syndrome. Blood (2012) 0.98
Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. Orphanet J Rare Dis (2013) 0.97
Ethical considerations associated with clinical use of next-generation sequencing in children. J Pediatr (2011) 0.97
Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologue. Proc Natl Acad Sci U S A (2002) 0.96
Recycling of the membrane-anchored chemokine, CX3CL1. J Biol Chem (2005) 0.96
Granulocyte chemotaxis and disease expression are differentially regulated by GRK subtype in an acute inflammatory arthritis model (K/BxN). Clin Immunol (2008) 0.96
Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration. Hum Genomics (2011) 0.95
Integrative "omic" analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes. Am J Respir Crit Care Med (2014) 0.94
Abnormal development of thymic dendritic and epithelial cells in human X-linked severe combined immunodeficiency. Clin Immunol (2004) 0.93
Molecular dynamic simulations of the metallo-beta-lactamase from Bacteroides fragilis in the presence and absence of a tight-binding inhibitor. J Mol Model (2008) 0.92
Enhanced Th17-cell responses render CCR2-deficient mice more susceptible for autoimmune arthritis. PLoS One (2011) 0.91
AIRE recruits multiple transcriptional components to specific genomic regions through tethering to nuclear matrix. Mol Immunol (2005) 0.91
Defective antitumor responses in CX3CR1-deficient mice. Int J Cancer (2007) 0.90
B cell-ablative therapy for the treatment of autoimmune diseases. Arthritis Rheum (2002) 0.88
Decreased Th17 and antigen-specific humoral responses in CX₃ CR1-deficient mice in the collagen-induced arthritis model. Arthritis Rheum (2012) 0.87
The chemokine CX3CL1 regulates NK cell activity in vivo. Cell Immunol (2003) 0.87
Baseline myocardial perfusion predicts response to cardiac resynchronization therapy: a prospective observational study. J Interv Card Electrophysiol (2008) 0.85
Chemokine CCL18 predicts intraventricular hemorrhage in very preterm infants. Ann Med (2010) 0.85
Development of a microarray platform for FFPET profiling: application to the classification of human tumors. J Transl Med (2009) 0.84
Clustered charged amino acids of human adenosine deaminase comprise a functional epitope for binding the adenosine deaminase complexing protein CD26/dipeptidyl peptidase IV. J Biol Chem (2002) 0.83
Loss of function variants in human PNPLA8 encoding calcium-independent phospholipase A2 γ recapitulate the mitochondriopathy of the homologous null mouse. Hum Mutat (2015) 0.83
cDNA targets improve whole blood gene expression profiling and enhance detection of pharmocodynamic biomarkers: a quantitative platform analysis. J Transl Med (2010) 0.83
Dual targeting of CCR2 and CX3CR1 in an arterial injury model of vascular inflammation. Thromb J (2010) 0.82
Suboptimal neurodevelopment in very preterm infants is related to fetal cardiovascular compromise in placental insufficiency. Am J Obstet Gynecol (2005) 0.81
Development of a phylogenetic tree model to investigate the role of genetic mutations in endometrial tumors. Oncol Rep (2011) 0.81
Evaluation of cytokines and hormones in dogs before and after treatment of diabetic ketoacidosis and in uncomplicated diabetes mellitus. Vet Immunol Immunopathol (2012) 0.81
Remote magnetic navigation system provides a superior catheter stability in acquisition of His bundle electrogram. J Interv Card Electrophysiol (2008) 0.79
Incidental swimming with millstones. Sci Transl Med (2013) 0.79
Combined DOCK8 and CLEC7A mutations causing immunodeficiency in 3 brothers with diarrhea, eczema, and infections. J Allergy Clin Immunol (2013) 0.79
Cord blood chemokines differentiate between spontaneous and elective preterm births in singleton pregnancies. Cytokine (2011) 0.78
Sepsis progression and outcome: a dynamical model. Theor Biol Med Model (2006) 0.78
Perinatal immunoproteins predict the risk of cerebral palsy in preterm children. Ann Med (2011) 0.76
Utility of next generation sequencing in clinical primary immunodeficiencies. Curr Allergy Asthma Rep (2014) 0.76
Pilot study to evaluate the effect of oral supplementation of Enterococcus faecium SF68 on cats with latent feline herpesvirus 1. J Feline Med Surg (2009) 0.76
Polymorphisms of the gene encoding Kit ligand are associated with bronchopulmonary dysplasia. Pediatr Pulmonol (2014) 0.76
Usefulness of desirable lifestyle factors to attenuate the risk of heart failure among offspring whose parents had myocardial infarction before age 55 years. Am J Cardiol (2012) 0.75
B cell loss leading to remission in severe systemic lupus erythematosus. J Rheumatol (2003) 0.75